GEHC vs ZTS — Key Metrics

Metric GEHC (GE HEALTHCARE TECHNOLOGIES INC) ZTS (ZOETIS INC)
Price83.6685.57
Market Cap37.83 Billion34.77 Billion
P/E (TTM)17.6514.53
P/B (Quarterly)2.95210.101
P/S (TTM)1.753.66
Net Profit Margin (TTM)10.026.1
Gross Margin (TTM)39.971.4
ROE (TTM)19.776.4
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

GE HEALTHCARE TECHNOLOGIES INC
vs
 
ZOETIS INC
 
GE HEALTHCARE TECHNOLOGIES INC
vs
 
ZOETIS INC
Performance Comparison
AI Model Recommendation
GEHC · GE HEALTHCARE TECHNOLOGIES INC

Outperform

29
UnderperformOutperform
ZTS · ZOETIS INC

Greatly Outperform

68
UnderperformOutperform
Recommendation Summary

Stock GEHC is projected to outperform the market, stock ZTS is projected to greatly outperform the market. Upfront Recommendation: ZTS.

Financial Metrics
Prices delayed ~15 min
GEHC Metrics ZTS
$83.66 Price $85.57
— Market Capitalization —
17.65 Price to Earnings Ratio 14.53
1.75 Price to Sales 3.66
20.02 Price to FCF Ratio 15.2
4.38 Price to Gross Profit 5.13
28.85 Price to R&D 47.89
3.29 Price to Current Assets 5.52

GEHC vs ZTS at a glance

GE Healthcare Technologies INC (GEHC) and Zoetis INC (ZTS) are both in the Healthcare sector. They are similar in size: $37.8 billion and $34.8 billion in market value.

On trailing-twelve-month figures, GEHC trades at 17.6 times trailing earnings and ZTS at 14.5; net profit margins are 10.0% and 26.1%.

The Upfront Investment model currently rates GEHC Outperform and ZTS Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.